JPS55102512A - Blend and its administration - Google Patents
Blend and its administrationInfo
- Publication number
- JPS55102512A JPS55102512A JP519880A JP519880A JPS55102512A JP S55102512 A JPS55102512 A JP S55102512A JP 519880 A JP519880 A JP 519880A JP 519880 A JP519880 A JP 519880A JP S55102512 A JPS55102512 A JP S55102512A
- Authority
- JP
- Japan
- Prior art keywords
- water
- blend
- administration
- prostaglandin
- intravaginal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7900737A SE431821B (sv) | 1979-01-29 | 1979-01-29 | Lagringsstabilt, prostaglandininnehallande medicinskt preparat |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55102512A true JPS55102512A (en) | 1980-08-05 |
JPH0140013B2 JPH0140013B2 (US07714131-20100511-C00024.png) | 1989-08-24 |
Family
ID=20337129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP519880A Granted JPS55102512A (en) | 1979-01-29 | 1980-01-18 | Blend and its administration |
Country Status (10)
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5731607A (en) * | 1980-06-20 | 1982-02-20 | Crinos Industria Farmaco | Spermicidal composition for local use |
JPH01221318A (ja) * | 1988-03-01 | 1989-09-04 | Masao Igarashi | ダナゾール含有の局所投与製剤 |
WO1993008804A1 (en) * | 1991-11-08 | 1993-05-13 | Kyoto Pharmaceutical Industries, Ltd. | Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2047093B (en) * | 1979-03-21 | 1983-12-07 | Graham N B | Controlled release compositions |
US5079009A (en) * | 1979-03-21 | 1992-01-07 | National Research Development Corporation | Controlled release compositions including polyethylene oxide with urethane cross-linking |
ZA831186B (en) * | 1982-03-22 | 1983-11-30 | Upjohn Ltd | Gelled pge2/triacetin solutions |
AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
US4675182A (en) * | 1983-02-12 | 1987-06-23 | Bayer Aktiengesellschaft | Complexes of prostaglandins |
DE3307816A1 (de) * | 1983-03-02 | 1984-09-06 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandin-haltiges pharmazeutisches praeparat und seine herstellung |
GB8403360D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
DE3428264A1 (de) * | 1984-07-27 | 1986-03-06 | Schering Ag | Gelhaltige pharmazeutische zubereitungen |
IE59361B1 (en) * | 1986-01-24 | 1994-02-09 | Akzo Nv | Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
JPH03220201A (ja) * | 1988-11-18 | 1991-09-27 | Eisai Co Ltd | プロスタグランジン類と多糖類の結合体 |
CH678697A5 (US07714131-20100511-C00024.png) * | 1989-04-03 | 1991-10-31 | Warner Lambert Co | |
US6946442B2 (en) * | 1994-11-30 | 2005-09-20 | Asif Syed Ahmed | Method of hastening cervical ripening |
DE69624564T2 (de) * | 1995-06-01 | 2003-03-20 | G.D. Searle & Co., Chicago | Misoprostolhaltige feste stabilisierte dispersionen |
US6103765A (en) | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
JP2001509480A (ja) | 1997-07-09 | 2001-07-24 | アンドロソリューションズ,インク. | 男性勃起機能不全を治療するための改良された方法及び組成物 |
FR2766709B1 (fr) | 1997-07-31 | 2000-04-07 | Dominique Cingotti | Procede pour la preparation d'un extrait de principes actifs sous forme de microgranules a base de fibres alimentaires entierement solubles destines a differentes formes galeniques |
US5891915A (en) * | 1998-05-01 | 1999-04-06 | Wysor; Michael S. | Method for enhancing female sexual response and an ointment therefor |
US6031002A (en) * | 1998-05-01 | 2000-02-29 | Michael Ebert | Method for enhancing female sexual response and a composition therefor |
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US20070191320A1 (en) * | 1998-12-10 | 2007-08-16 | Nexmed Holdings, Inc. | Methods of treatment for female sexual arousal disorder |
US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
GR1004266B (el) * | 2001-04-30 | 2003-06-18 | Ηλιας Κ. Παπαδοπουλος | Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας |
US20050181030A1 (en) * | 2003-01-03 | 2005-08-18 | Mo Y. J. | Topical stabilized prostaglandin E compound dosage forms |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51125142A (en) * | 1974-06-27 | 1976-11-01 | Ciba Geigy Ag | Process for producing waterrinsoluble hydrophilic copolymer |
JPS5256148A (en) * | 1975-10-16 | 1977-05-09 | Agency Of Ind Science & Technol | Process for preparing active substances having improved |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3948254A (en) * | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
US3875300A (en) * | 1972-12-18 | 1975-04-01 | Ortho Pharma Corp | Composition for sustained release of a medicament and method of using same |
US3888975A (en) * | 1972-12-27 | 1975-06-10 | Alza Corp | Erodible intrauterine device |
US4036954A (en) | 1973-11-02 | 1977-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Stable prostaglandin E group-containing formulation |
AR205997A1 (es) | 1973-11-21 | 1976-06-23 | American Cyanamid Co | Resina de poliester normalmente solida biodegradable e hidrolizable |
US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
GB1554783A (en) | 1976-01-05 | 1979-10-31 | Population Res Inc | Pharmaceutical compositions for use in the permanent sterilization of female animals |
US4145555A (en) * | 1976-03-12 | 1979-03-20 | Ono Pharmaceutical Company | Δ3 -Prostaglandin analogs |
GB1551620A (en) * | 1976-12-13 | 1979-08-30 | Ici Ltd | Delivery means for biologically active agents |
-
1979
- 1979-01-29 SE SE7900737A patent/SE431821B/sv not_active IP Right Cessation
- 1979-12-17 SE SE7910354A patent/SE442167B/sv not_active IP Right Cessation
-
1980
- 1980-01-14 GB GB8001176A patent/GB2041220B/en not_active Expired
- 1980-01-16 DE DE19803001454 patent/DE3001454A1/de active Granted
- 1980-01-16 US US06/112,563 patent/US4352790A/en not_active Expired - Lifetime
- 1980-01-18 JP JP519880A patent/JPS55102512A/ja active Granted
- 1980-01-23 NL NL8000426A patent/NL190693C/xx not_active IP Right Cessation
- 1980-01-25 BE BE0/199113A patent/BE881351A/fr not_active IP Right Cessation
- 1980-01-25 NO NO800186A patent/NO153520C/no unknown
- 1980-01-28 FR FR8001797A patent/FR2447191A1/fr active Granted
- 1980-01-28 DK DK033580A patent/DK160739C/da not_active IP Right Cessation
-
1986
- 1986-07-03 DK DK316186A patent/DK160740C/da not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51125142A (en) * | 1974-06-27 | 1976-11-01 | Ciba Geigy Ag | Process for producing waterrinsoluble hydrophilic copolymer |
JPS5256148A (en) * | 1975-10-16 | 1977-05-09 | Agency Of Ind Science & Technol | Process for preparing active substances having improved |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5731607A (en) * | 1980-06-20 | 1982-02-20 | Crinos Industria Farmaco | Spermicidal composition for local use |
JPH0371403B2 (US07714131-20100511-C00024.png) * | 1980-06-20 | 1991-11-13 | Kurinosu Ind Fuarumakobiorojika Spa | |
JPH01221318A (ja) * | 1988-03-01 | 1989-09-04 | Masao Igarashi | ダナゾール含有の局所投与製剤 |
WO1993008804A1 (en) * | 1991-11-08 | 1993-05-13 | Kyoto Pharmaceutical Industries, Ltd. | Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
Also Published As
Publication number | Publication date |
---|---|
DK160739C (da) | 1991-09-30 |
FR2447191B1 (US07714131-20100511-C00024.png) | 1983-07-22 |
NL190693B (nl) | 1994-02-01 |
NL190693C (nl) | 1994-07-01 |
GB2041220A (en) | 1980-09-10 |
NO153520C (no) | 1986-04-09 |
GB2041220B (en) | 1983-07-27 |
DK33580A (da) | 1980-07-30 |
SE431821B (sv) | 1984-03-05 |
BE881351A (fr) | 1980-05-16 |
DK316186D0 (da) | 1986-07-03 |
FR2447191A1 (fr) | 1980-08-22 |
DE3001454C2 (US07714131-20100511-C00024.png) | 1990-05-10 |
NO153520B (no) | 1985-12-30 |
US4352790A (en) | 1982-10-05 |
DK160740C (da) | 1991-09-30 |
NL8000426A (nl) | 1980-07-31 |
SE7910354L (sv) | 1980-07-30 |
SE442167B (sv) | 1985-12-09 |
JPH0140013B2 (US07714131-20100511-C00024.png) | 1989-08-24 |
DK160739B (da) | 1991-04-15 |
NO800186L (no) | 1980-07-30 |
DK316186A (da) | 1986-07-03 |
DE3001454A1 (de) | 1980-08-07 |
SE7900737L (sv) | 1980-07-30 |
DK160740B (da) | 1991-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS55102512A (en) | Blend and its administration | |
DE3068570D1 (en) | Pharmaceutical composition in the form of a polyacrylate film, and its preparation | |
ES386819A1 (es) | Procedimiento para la obtencion de preparados ligadores delacido bilico. | |
NO152635C (no) | Fremgangsmaate for fremstilling av cyklosporinholdige farmasoeytiske preparater i flytende form | |
FI900052A0 (fi) | Kompositioner och behandlingsmetoder foer hemorrojder och annat. | |
SE8501370D0 (sv) | Lagerstabila snabbsonderfallande farmaceutiska presstycken av verksamt material | |
SE8104661L (sv) | Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav | |
AU557927B2 (en) | Preparation of binderless 3a adsorbents use to dry h/c:s | |
NO172726C (no) | Absorberende forbindingsmateriale eller hygieneprodukt i vannuopploeselig form | |
GB2146526B (en) | Preparations for the transdermal application of active substances | |
GR3026563T3 (en) | Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method | |
NZ218948A (en) | Pharmaceutical preparations containing viscous gels for administration by syringe | |
SE7906467L (sv) | Hypo-beta-lipoproteinemiskt dietikum, forfarande for framstellning derav och anvendning derav | |
KR900015768A (ko) | 고형겔 외용약 전달 시스템 | |
SE8103833L (sv) | Spermiedodande komposition | |
SE7904307L (sv) | Forfarande for framstellning av vattenolosliga absorptionsmedel | |
DE3264331D1 (en) | Aqueous preparation and its use in the preparation of ceramic masses | |
ATE82126T1 (de) | Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck. | |
JPS55118414A (en) | Prolonged release drug and its preparation | |
DE3066533D1 (en) | Optically active cephalosporin analogs, process for their preparation and their use in the preparation of pharmaceutical compositions | |
ATE15329T1 (de) | Pharmazeutische grundmasse und praeparate. | |
DE2963584D1 (en) | Stable, liquid pharmaceutical formulation, its preparation and use | |
JPS55149212A (en) | Gradually releasing preparation of methotrexate | |
Greenwood, Frank & Samuel | Benign ulcers on the greater curvature of the stomach | |
ES8300468A1 (es) | "un metodo para fabricar una tableta masticable". |